Phase 1b dose-finding study of avelumab (anti-PD-L1) + axitinib in treatment-naive patients with advanced renal cell carcinoma.
Larkin, J Rini, B Thistlethwaite, Fiona C Gordon, M Martgnoni, M Magazzu, D Chiruzzi, C Di Pietro, A Choueiri, T
Larkin, J
Rini, B
Thistlethwaite, Fiona C
Gordon, M
Martgnoni, M
Magazzu, D
Chiruzzi, C
Di Pietro, A
Choueiri, T
Citations
Altmetric:
Abstract
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Phase 1b dose-finding study of avelumab (anti-PD-L1) + axitinib in treatment-naive patients with advanced renal cell carcinoma. 2016, 27(suppl_6): 775PD Ann Oncol